Topic

Biopharmaceuticals

A collection of 1 issue

Maze Therapeutics' Key Advances in Chronic Kidney Disease Therapies

Explore Maze Therapeutics' progress with MZE829 and MZE782, innovative treatments targeting chronic kidney disease. Learn more about these leading programs.